Search Results 2061-2070 of 19165 for prostate cancer

  1. A Study of ASTX660 Alone or Combined with ASTX727 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) - Mayo Clinic

    Second malignancy currently requiring active therapy, except breast or prostate cancer stable on or responding to endocrine therapy. Graft Versus Host ...

  2. Publications - Indravadan J. Patel, M.D. - Mayo Clinic

    ... Prostate Gland. Radiology. 2019 Sep; 292 (3):685-694 Epub 2019 July 23. View PubMed; Davidson JC, Rahim S, Hanks SE, Patel IJ, Tam AL, Walker TG, Weinberg I ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Proton therapy, Head and neck cancer, Prostate cancer, Bladder cancer, Testicular cancer, Breast cancer. Research. Doctors discussing imaging test results.

  4. Publications - Scott C. Lester, M.D. - Mayo Clinic

    Cancer in Patients With Incidental Asymmetric Oropharynx Positron Emission ... Prostate Cancer With High-Risk Features After Radical Prostatectomy. Adv ...

  5. Publications - Payam Entezami, M.D., M.S. - Mayo Clinic

    Bone marrow macrophages support prostate cancer growth in bone. Oncotarget. 2015 Nov 3; 6 (34):35782-96. View PubMed; Kuroshima S, Entezami P, McCauley LK ...

  6. Publications - Jon J. Kruse, Ph.D. - Mayo Clinic

    Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer. Int J Part Ther. 2024 Jun; 12:100015 Epub 2024 Apr 24

  7. Homan Mohammadi, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... cancer; Laryngeal cancer; Nasopharyngeal carcinoma; Oral and throat cancer; Oropharyngeal cancer; Prostate cancer; Salivary gland cancer; Skin cancer · Thyroid ...

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Cancer treatment, Stereotactic body radiotherapy, Head and neck cancer, Prostate cancer, Breast cancer, Lung cancer. Roberto A ...

  9. Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other Myelodysplastic /Myeloproliferative Neoplasias, and Acute Myeloid Leukemia - Mayo Clinic

    ... cancer, adjuvant hormonal therapy for breast cancer and hormonal treatment for castration sensitive prostate cancer). Active and uncontrolled bacterial ...

  10. A Study to Evaluate Induction Chemotherapy with ABVD Followed by Brentuximab Vedotin Consolidation in Previously-untreated, Non-bulky Stage I or II Hodgkin Lymphoma - Mayo Clinic

    Non-melanoma skin cancer; Cervical carcinoma in situ without evidence of disease; Prostatic intraepithelial neoplasia without evidence of prostate cancer.